Breaking News Instant updates and real-time market news.

SCS

Steelcase

$16.10

0.8 (5.23%)

, ACAD

Acadia

$19.08

3.97 (26.27%)

19:09
09/20/18
09/20
19:09
09/20/18
19:09

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Steelcase (SCS) up 15.2%. ALSO HIGHER: Acadia Pharma (ACAD) up 3.6% after FDA statement affirming risk profile of Nuplazid... Texas Instruments (TXN) up 0.9% after raising dividend and announcing $12B stock buyback... McDonalds (MCD) up 0.4% after dividend increase and affirmed long-term guidance... Royal Dutch Shell (RDS) up 0.3% after reported $1.3B sale of Gulf Coast assets. DOWN AFTER EARNINGS: Pier 1 Imports (PIR) down 18.2%... United Natural Foods (UNFI) down 11.3%... Micron (MU) down 6.9%. ALSO LOWER: Smart Global (SGH) down 4.5% after mixed shelf offering.

SCS

Steelcase

$16.10

0.8 (5.23%)

ACAD

Acadia

$19.08

3.97 (26.27%)

TXN

Texas Instruments

$108.50

1.14 (1.06%)

MCD

McDonald's

$160.84

1.65 (1.04%)

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

MU

Micron

$46.06

1.01 (2.24%)

SGH

Smart Global

$30.44

0.7 (2.35%)

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 01

    Oct

  • 04

    Oct

  • 10

    Oct

  • 28

    Oct

SCS Steelcase
$16.10

0.8 (5.23%)

ACAD Acadia
$19.08

3.97 (26.27%)

09/20/18
COWN
09/20/18
NO CHANGE
COWN
Outperform
Cowen says FDA news should 'go a long way' in easing Nuplazid safety concerns
After the FDA announced that it has concluded there is no new risk associated with Nuplazid, Cowen analyst Ritu Baral said she thinks the FDA's statement will go a long way in easing patient safety concerns. The analyst, who sees the FDA news as "very likely" to boost Nuplazid back to growth soon, keeps an Outperform rating on Acadia shares.
09/20/18
JMPS
09/20/18
NO CHANGE
JMPS
FDA safety review a 'signal of confidence' in Acadia drug, says JMP Securities
JMP Securities analyst Jason Butler reiterated a Market Outperform rating and $27 price target on Acadia Pharmaceuticals after the FDA reaffirmed its confidence in Nuplazid safety profile following completion of a comprehensive safety review. Butler sees this as an "important signal of confidence in the drug's safety profile" and sees this as a clearing event for the stock. He sees these catalysts driving the stock meaningfully higher in the coming months.
09/20/18
PIPR
09/20/18
UPGRADE
PIPR
Overweight
Acadia upgraded to Overweight from Neutral at Piper Jaffray
09/20/18
PIPR
09/20/18
UPGRADE
Target $25
PIPR
Overweight
Acadia upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Danielle Brill upgraded Acadia Pharma to Overweight from Neutral and raised her price target to $25 from $16 after the FDA announcement of maintained support for Nuplazid after its review. The analyst says that while the decision was expected, the press-release format of announcement was surprising and serves as a "clear message that should diminish lingering concerns from patients/providers". Brill anticipates accelerate Rx growth for Nuplazid moving forward, raising her prescription drug plan estimate for the program to $750M from $600M.
TXN Texas Instruments
$108.50

1.14 (1.06%)

08/14/18
MZHO
08/14/18
NO CHANGE
MZHO
Buy
ON Semiconductor pullback a buying opportunity, says Mizuho
Mizuho analyst Vijay Rakesh views the recent pullback in shares of ON Semiconductor (ON) as a buying opportunity. The analyst attributes the selloff to concerns of a peaking semi cycle, but points out that over the last four-years, ON's exposure to auto and industrial revenue has almost doubled. However, the stock trades at a 50% discount to automotive and industrial peers including Texas Instruments (TXN), NXP Semiconductors (NXPI), Analog Devices (ADI), Maxim Integrated (MXIM) and Monolithic Power (MPWR), Rakesh tells investors in a research note.
07/31/18
LOOP
07/31/18
NO CHANGE
Target $70
LOOP
Buy
Texas Instruments to generate above-consensus revenue, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $70 price target on Texas Instruments, saying the company should continue tracking with stronger than expected revenue, earnings, and gross margins. The analyst notes that while the current quarter is less favorable than the prior one, the revenue mix will improve amid the ramp in demand for Cloud drives "through at least 2019", the increase in demand for Edge applications such as video surveillance, and the start of ramp of Enterprise SSDs using NAND memory.
09/17/18
09/17/18
DOWNGRADE
Target $47

Underweight
Sensata downgraded to Underweight on rising cyclical risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Craig Hettenbach downgraded Sensata (ST) to Underweight from Equal Weight as he thinks a recent slowing across its end markets, particularly autos, which make up 60% of sales, increase the risk of a miss in Q4. He notes that the stock has held up much better in the last few weeks than other semi companies - such as Texas Instruments (TXN), ON Semiconductor (ON) and Cypress Semiconductor (CY) - facing similar risks, which leads Hettenbach to think Sensata is more susceptible to any disappointment. While the key driver of his downgrade is cyclical concerns, the analyst also noted that he is keeping an eye on the increased traction that TE Connectivity (TEL) and Amphenol (APH) are seeing in sensors. Hettenbach lowered his price target on Sensata shares to $47 from $55.
07/25/18
JEFF
07/25/18
NO CHANGE
Target $157
JEFF
Buy
Texas Instruments price target raised to $157 from $150 at Jefferies
Jefferies analyst Mark Lipacis raised his price target for Texas Instruments to $157 saying his conviction is increased following last night's Q2 results. The Street is underestimating the company's revenue growth and margin potential, Lipacis tells investors in a research note. He believes Texas Instruments' operating margins will expand another 1,000 basis points over the next 3-to-5 years to 50%. Lipacis reiterates a Buy rating on the shares.
MCD McDonald's
$160.84

1.65 (1.04%)

08/30/18
RBCM
08/30/18
NO CHANGE
Target $18
RBCM
Sector Perform
Wendy's free cash flows and earnings to start normalizing, says RBC Capital
RBC Capital analyst David Palmer kept his Sector Perform rating and $18 price target on Wendy's (WEN) ahead of its roadshow event on September 5th. The analyst notes that while he sees a path to FY19 and FY20 EPS growth of 20% on higher share repurchase assumptions, long term revenue growth should stay around 3%-4% and comps at 1%-2%. Palmer adds that Wendy's may be faced with growing competitive pressure and share losses to "delivery aggregators and improving execution by McDonald's (MCD), Panera, and Chick-Fil-A."
08/21/18
CLVD
08/21/18
NO CHANGE
CLVD
McDonald's focused on value ramping in 2H, says Cleveland Research
Cleveland Research said McDonald's has increased its focus on value in 2H in order to spur traffic following underwhelming 1H performance. The firm's analyst is forecasting in-line Q3 comps with consensus and said it is unclear yet if the value initiatives have resulted in a sales lift.
08/21/18
SPHN
08/21/18
NO CHANGE
Target $73
SPHN
Overweight
Stephens has 'mixed' view of Tyson Foods deal for Keystone
After Tyson Food (TSN) announced an agreement to buy Keystone Foods from Marfrig for $2.16B in cash, Stephens analyst Farha Aslam said she has a "mixed" view of the deal, noting that the transaction does offer significant synergy opportunities, but that it also increase the company's exposure to McDonald's (MCD), which offers steady business but at thin margins. Still, Aslam reiterated her Overweight rating and $73 price target on Tyson shares.
08/08/18
WELS
08/08/18
NO CHANGE
Target $185
WELS
Outperform
McDonald's price target raised to $185 from $180 at Wells Fargo
Wells Fargo analyst Jon Tower raised his price target for McDonald's to $185 from $180 as he believes it will see an acceleration in 2H18 U.S. same-store sales predicated on the combination of abating Experience of the Future headwinds and increased deals and evolved value messaging. The analyst sees this same-store sales growth further picking up steam in 2019 with the EOTF program flipping from a same-store sales headwind to a tailwind, the frequency and depth of value deals remaining high and McDonald's making a small, but powerful change to its delivery program. He reiterates an Outperform rating on the shares.
RDS.A Royal Dutch Shell
$66.83

0.57 (0.86%)

09/11/18
BREN
09/11/18
INITIATION
BREN
Hold
Royal Dutch Shell initiated with a Hold at Berenberg
Berenberg analyst Henry Tarr started Royal Dutch Shell with a Hold rating and EUR 31 price target.
08/02/18
08/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hanesbrands (HBI) downgraded to Equal Weight from Overweight at Barclays with analyst Chethan Mallela saying he sees a lack of visibility into the second half of the year following the company's Q2 results. 2. Royal Dutch Shell (RDS.A) downgraded to Equal Weight from Overweight at Morgan Stanley. 3. Verisk Analytics (VRSK) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Arash Soleimani citing valuation. 4. People's Utah Bancorp (PUB) downgraded to Market Perform at Raymond James with analyst David Long citing valuation. 5. Wendy's (WEN) downgraded to Neutral ahead of Q2 report at Kalinowski with analyst Mark Kalinowski saying his checks indicate July same-store-sales are trending below the +1.5% level and were the worst checks since February 2012. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/31/18
08/31/18
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. BP (BP) and Royal Dutch Shell (RDS.A) were upgraded to Hold from Underperform at Santander. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory. 3. Electronic Arts (EA) and Activision Blizzard (ATVI) were downgraded to Neutral from Buy at BofA/Merrill. 4. Gain Capital (GCAP) initiated with a Neutral at JPMorgan. 5. Avaya (AVYA) initiated with a Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/31/18
SANT
08/31/18
UPGRADE
SANT
Hold
Royal Dutch Shell upgraded to Hold from Underperform at Santander
PIR Pier 1 Imports
$1.80

0.045 (2.56%)

09/20/18
LOOP
09/20/18
NO CHANGE
Target $1.5
LOOP
Hold
Pier 1 Imports price target lowered to $1.50 at Loop Capital after soft Q2
Loop Capital analyst Anthony Chukumba lowered his price target on Pier 1 Imports to $1.50 from $2.00 and kept his Hold rating after its worse-than-expected preliminary Q2 results and withdrawn FY18 guidance. The analyst says this latest update affirms his belief that a turnaround will be more difficult to execute this time around because of a "much more competitive environment", growing e-commerce sales, and having a lot less costs that the company can reduce.
04/19/18
LOOP
04/19/18
NO CHANGE
Target $3
LOOP
Hold
Pier 1 Imports price target lowered to $3 at Loop Capital following Analyst Day
Loop Capital analyst Anthony Chukumba lowered his price target on Pier 1 to $3 from $4 and kept his Hold rating. The analyst contends that the management presented a "comprehensive" turnaround strategy but prefers to see more concrete signs of progress before turning more constructive on the stock. Chukumba still sees a number of risks associated with the stock such as poor consumer response to Pier 1's merchandise, heightened competition from online furnishing retailers, and further margin pressure from discounting.
06/28/18
LOOP
06/28/18
NO CHANGE
Target $2
LOOP
Hold
Pier 1 Imports' back-half weighted guidance 'concerning,' says Loop Capital
Loop Capital analyst Chukumba lowered his price target on Pier 1 Imports to $2 from $3 and maintained a Hold rating after the company reported Q1 results, telling investors in a research note that there was nothing in the company's performance during the quarter that gave him any indication it is going to "turn the corner" any time soon. Additionally, the analyst says he is "concerned" that the company's FY18 guidance is more back-half weighted than he originally expected, and that the company's plans to introduce more modern merchandise gives him "bad memories" of the last time it tried a similar strategy.
04/23/18
RAJA
04/23/18
DOWNGRADE
RAJA
Underperform
Pier 1 Imports downgraded to Underperform from Market Perform at Raymond James
UNFI United Natural Foods
$33.83

0.54 (1.62%)

07/27/18
RBCM
07/27/18
DOWNGRADE
Target $33
RBCM
Sector Perform
Supervalu downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Bill Kirk downgraded Supervalu (SVU) to Sector Perform from Outperform and lowered his price target to $33 from $39 after its announced acquisition by United Natural Foods (UNFI) at $32.50 per share.
09/12/18
LOOP
09/12/18
NO CHANGE
Target $55
LOOP
Buy
United Natural Foods remains 'undervalued', says Loop Capital
Loop Capital analyst Andrew Wolf kept his Buy rating and $55 price target on United Natural Foods ahead of its September 20th earnings report. The analyst contends that he expects "strong" revenue growth and "solid" profit gains amid the high demand for "natural/organic products" given with the company's "leading position in distribution". Wolf also maintains that United Natural Foods is "undervalued", trading at a discount to each member of its Specialty Food Distributor peer group.
08/06/18
WELS
08/06/18
NO CHANGE
Target $33
WELS
Market Perform
Supervalu price target raised to $33 from $21 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for Supervalu (SVU) to $33 from $21 after the company announced last week that it has agreed to be acquired by United Natural Foods (UNFI) for $32.50/share in cash, or $2.9B. The analyst says the deal makes sense to him from Supervalu's perspective given the company's strategic repositioning in recent years toward pure-play wholesale. He reiterates a Market Perform rating on Supervalu shares.
07/27/18
LOOP
07/27/18
NO CHANGE
Target $55
LOOP
Buy
United Natural Foods price target lowered to $55 from $61 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on United Natural Foods (UNFI) to $55, citing expectations of a significant leverage increase from the company's surprising $2.9B acquisition of Supervalu (SVU). Wolf also keeps his Buy rating on United Natural Foods, saying the deal marks an acceleration of the company's current acquisition strategy in an effort to diversify its product and customer mix. The analyst is positive on the deal as "Supervalu is particularly strong in certain specialty food categories in which United Natural Foods is lacking."
MU Micron
$46.06

1.01 (2.24%)

09/18/18
COWN
09/18/18
NO CHANGE
Target $62
COWN
Outperform
Micron price target lowered to $62 from $72 at Cowen
Cowen analyst Karl Ackerman lowered his price target on Micron to $62 from $72 on expectations the company will guide lower for the first time in eight quarters, but he believes that could already be priced into the shares. The analyst noted investor sentiment is "dreadful" heading into results and he sees incremental risk in the second half of the year. Ackerman maintained his Outperform rating on Micron shares.
09/18/18
RBCM
09/18/18
NO CHANGE
Target $70
RBCM
Outperform
Micron may initiate buyback program, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $70 price target on Micron ahead of its Q4 earnings this week, saying the company should report "slightly above" the midpoint of its prior guidance. The analyst also expects investors to focus on Micron's outlook for memory pricing in Q1, which he estimates to be down 11%-12% in NAND ASPs and low-to-mid single digit in DRAM ASPs. Daryanani adds that an update on the cost scale-down reflecting the lower price expectations could also be key toward sustaining Micron's gross margins. The analyst further expects Micron to initiate a potentially "aggressive" buyback program given the current price levels.
09/14/18
WELS
09/14/18
NO CHANGE
Target $63
WELS
Outperform
Wells Fargo recommends buying Micron, sees positive long-term trends
Ahead of Micron Technology's fiscal Q4 earnings release on September 20, Wells Fargo analyst Aaron Rakers maintains his below-consensus estimates for the company. While near-term trends in DRAM and NAND have weakened, this "overshadows a positive long-term secular trend," Rakers told investors last night in a pre-earnings research note. The analyst believes the "capex intensity and complexity" associated with next generation memory technology transitions, coupled with expanding end market demand, will ultimately result in a "more rational supply/demand environment." As such, Rakers recommends buying shares of Micron at current levels. He points out the shares trade at a 4.3 times price-to-earnings ratio and 2.5 times enterprise value-to-EBITDA on his 2019 estimates. Further, Micron will likely maintain its $10B share repurchase authorization commencing in the current quarter, Rakers contends. He keeps an Outperform rating on Micron with a $63 price target. The stock in early trading is up 11c to $43.73
09/17/18
DBAB
09/17/18
NO CHANGE
Target $60
DBAB
Buy
Deutsche still sees 35% upside in Micron after cutting price target to $60
Deutsche Bank analyst Sidney Ho lowered his price target for Micron Technology to $60 from $80 ahead of the company's fiscal Q4 results but keeps a Buy rating on the shares. The analyst reduced his estimates for the out-quarters to reflect the recent deterioration of NAND and DRAM pricing. Ho dropped his fiscal Q1 earnings estimate by 9% and fiscal 2019 estimate by 20%. It appears we have passed the peak of the current memory cycle, Ho tells investors in a research note. While the analyst expects Micron's share price "to be choppy in the near term," he also sees "rational capital spending" by other memory suppliers leading to quicker stabilization of the market than previous cycles. He views Micron's risk/reward as attractive with the stock 35% below his new price target.
SGH Smart Global
$30.44

0.7 (2.35%)

06/22/18
STFL
06/22/18
NO CHANGE
Target $61
STFL
Buy
Smart Global price target raised to $61 from $56 at Stifel
Stifel analyst Kevin Cassidy said he believes Smart Global's "bold moves" to expand will accelerate growth while diversifying the company's end markets and noted that management stated along with the company's quarterly report that demand for PC's and smart phones in Brazil remains strong. Following the report Cassidy raised his revenue and EPS estimates for Smart Global and increased his price target on the stock to $61. He maintains a Buy rating on the name.
05/15/18
STFL
05/15/18
NO CHANGE
Target $101
STFL
Buy
NAND flash negativity creates buying opportunity in Micron, says Stifel
Stifel analyst Kevin Cassidy said DRAM prices are tracking above his previous estimates for the May-ending quarter, while the NAND flash market "is growing and far from collapsing, as the bear case has it." The NAND flash negativity is overdone, creating buying opportunities in Micron (MU), Smart Global (SGH) and Western Digital (WDC), according to Cassidy. He raised his price target on Micron shares to $101 from $95 while maintaining a Buy rating on the stock. The firm also has Buy ratings on Smart Global and Western Digital.
04/26/18
STFL
04/26/18
NO CHANGE
STFL
Signs points to continued strong demand for memory, says Stifel
Following the quarterly reports from SK Hynix and Samsung, Stifel analyst Kevin Cassidy said industry data points continue to suggest demand for memory remains strong, primarily from the data center. He also believes memory suppliers continue to act rationally in maintaining incremental supply growth. Cassidy added that his average selling price data in the May quarter to date is tracking ahead of his estimates for both Micron (MU) and SMART Global (SGH).
08/06/18
STFL
08/06/18
NO CHANGE
STFL
Stifel says Applied, Lam to be beneficiaries of NAND capital intensity step-up
Ahead of this week's upcoming Flash Memory Summit, Patrick Ho shared his view of how he expects capital intensity trends continue to increase as the NAND industry moves to 96 layers and above over the next few years. From a stocks perspective, he believes the biggest beneficiaries of the step-up will remain Applied Materials (AMAT) and Lam Research (LRCX), while also noting that MKS Instruments (MKSI) can benefit from its leadership position in many areas where it supplies both Applied and Lam. Stating that he supports Ho's view on the memory industry's increasing capital intensity, Stifel analyst Kevin Cassidy said in his own note to investors that he expects FMS conference keynotes to discuss the expanding markets for NAND Flash pushing total revenue and profits up despite the industry's increasing capital expenditures driving average selling prices lower. Cassidy also noted the first ever MRAM Developers Day will be held Monday, August 6, stating that he views this as significant for expanding the MRAM eco-system led by Everspin (MRAM). Other NAND Flash names Cassidy has previously been positive about include Micron (MU) and Smart Global (SGH).

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$48.89

0.65 (1.35%)

09:25
02/23/19
02/23
09:25
02/23/19
09:25
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CAT

Caterpillar

$138.77

-0.08 (-0.06%)

, XRX

Xerox

$31.50

0.16 (0.51%)

08:29
02/23/19
02/23
08:29
02/23/19
08:29
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CAT

Caterpillar

$138.77

-0.08 (-0.06%)

XRX

Xerox

$31.50

0.16 (0.51%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$14.81

0.02 (0.14%)

F

Ford

$8.71

(0.00%)

GM

General Motors

$39.98

0.35 (0.88%)

HMC

Honda

$28.17

0.43 (1.55%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$121.84

0.66 (0.54%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$31.51

-0.62 (-1.93%)

LUV

Southwest

$53.62

-0.69 (-1.27%)

VZ

Verizon

$56.95

0.81 (1.44%)

TMUS

T-Mobile

$73.17

-0.09 (-0.12%)

T

AT&T

$31.15

0.32 (1.04%)

NOK

Nokia

$6.21

0.06 (0.98%)

ERIC

Ericsson

$9.51

0.285 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 03

    Mar

  • 03

    Mar

  • 04

    Mar

  • 11

    Mar

  • 13

    Mar

  • 20

    Mar

  • 27

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

AIMT

Aimmune

$23.70

0.73 (3.18%)

, AZN

AstraZeneca

$40.95

0.515 (1.27%)

04:55
02/23/19
02/23
04:55
02/23/19
04:55
Conference/Events
The American Academy of Asthma, Allergy & Immunology to hold annual meeting »

AAAAI Annual Meeting 2019…

AIMT

Aimmune

$23.70

0.73 (3.18%)

AZN

AstraZeneca

$40.95

0.515 (1.27%)

TEVA

Teva

$17.28

0.03 (0.17%)

NVS

Novartis

$90.77

0.26 (0.29%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SHPG

Shire

$0.00

(0.00%)

REGN

Regeneron

$422.43

3.77 (0.90%)

SNY

Sanofi

$41.20

-0.13 (-0.31%)

ALK

Alaska Air

$62.35

-0.48 (-0.76%)

ABT

Abbott

$76.40

1.26 (1.68%)

CVS

CVS Health

$62.00

-0.33 (-0.53%)

KALV

KalVista

$20.74

-0.04 (-0.19%)

BCRX

BioCryst

$8.99

0.32 (3.69%)

OPTN

Optinose

$7.31

0.02 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 04

    Mar

  • 04

    Mar

  • 04

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

ETFC

E-Trade

$48.89

0.65 (1.35%)

04:55
02/23/19
02/23
04:55
02/23/19
04:55
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TEX

Terex

$35.29

-0.3 (-0.84%)

19:01
02/22/19
02/22
19:01
02/22/19
19:01
Hot Stocks
Terex to sell Demag Mobile Cranes business to Tadano for $215M enterprise value »

Terex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CZR

Caesars

$9.05

-0.37 (-3.93%)

18:34
02/22/19
02/22
18:34
02/22/19
18:34
Hot Stocks
Canyon Partners: Caesars shareholders' value best served by open sale process »

Canyon Partners issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$20.85

0.17 (0.82%)

, BA

Boeing

$424.05

6.57 (1.57%)

18:11
02/22/19
02/22
18:11
02/22/19
18:11
Periodicals
Brazilian judge suspends Embraer-Boeing deal talks, Reuters reports »

A Brazilian judge…

ERJ

Embraer

$20.85

0.17 (0.82%)

BA

Boeing

$424.05

6.57 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 14

    Mar

  • 28

    May

BXG

Bluegreen Vacations

$14.47

0.55 (3.95%)

18:02
02/22/19
02/22
18:02
02/22/19
18:02
Earnings
Bluegreen Vacations reports Q4 EPS 27c, consensus 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

SM

SM Energy

$16.88

-0.13 (-0.76%)

17:57
02/22/19
02/22
17:57
02/22/19
17:57
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy's higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$37.22

-1.15 (-3.00%)

17:47
02/22/19
02/22
17:47
02/22/19
17:47
Syndicate
Breaking Syndicate news story on AutoNation »

AutoNation files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

TSLA

Tesla

$294.60

3.42 (1.17%)

, NSANY

Nissan

$0.00

(0.00%)

17:42
02/22/19
02/22
17:42
02/22/19
17:42
Periodicals
Tesla's Model 3 was the highest-selling EV globally in 2018, Verge reports »

Tesla's (TSLA) Model…

TSLA

Tesla

$294.60

3.42 (1.17%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

FSFG

First Savings Financial Group

$51.33

0.22 (0.43%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Hot Stocks
First Savings Financial raises quarterly dividend to 16c per share from 15c »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$110.97

1.5 (1.37%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Periodicals
Employees demand Microsoft cancel $480M U.S. Army contract, Reuters says »

Several Microsoft workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

ENT

Global Eagle

$2.66

(0.00%)

17:23
02/22/19
02/22
17:23
02/22/19
17:23
Hot Stocks
Global Eagle to cut workforce by roughly 15% »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:15
02/22/19
02/22
17:15
02/22/19
17:15
General news
Breaking General news story  »

New York Federal Reserve…

NOC

Northrop Grumman

$288.84

2.54 (0.89%)

17:13
02/22/19
02/22
17:13
02/22/19
17:13
Hot Stocks
Northrop Grumman exec Kalan sells 4,312 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.